TSX:CRDL

Why Cardiol Therapeutics Stock Is Still in Focus While Nasdaq Is Closed

Why Cardiol Therapeutics Stock Is Still in Focus While Nasdaq Is Closed

Cardiol Therapeutics’ Toronto-listed shares rose 1.1% to C$1.84 on Monday, with light trading, as U.S. markets closed for Memorial Day. The company’s Phase III MAVERIC trial in recurrent pericarditis neared full enrollment, with 75% reached by April. Cardiol reported C$27.7 million in cash at March 31 and a first-quarter net loss of C$10.8 million. Management expects current cash to last into Q4 2027.
May 25, 2026

Stock Market Today

  • Megaport Shares Halted Amid 86% Surge, Signalling Potential Major Deal
    June 1, 2026, 11:45 PM EDT. Megaport Ltd (ASX: MP1) shares were halted Tuesday following an 86% surge over the past month, with the stock last trading at $16.61. The halt was requested as the cloud connectivity firm prepares to announce "new material commercial transactions," raising investor anticipation amid robust demand for cloud and AI infrastructure services. Megaport's market cap stands near A$2.95 billion, with recurring revenue exceeding A$338 million for H1 FY26. Trading suspension will last until an update is released or normal trading resumes Thursday. Investors await details to assess if recent gains fully reflect potential deal impacts in a stock that has nearly doubled from its 52-week low.